Page last updated: 2024-11-04

salicylsalicylic acid and Diabetes Mellitus, Adult-Onset

salicylsalicylic acid has been researched along with Diabetes Mellitus, Adult-Onset in 18 studies

salicylsalicylic acid: structure
salsalate : A dimeric benzoate ester obtained by intermolecular condensation between the carboxy of one molecule of salicylic acid with the phenol group of a second. It is a prodrug for salycylic acid that is used for treatment of rheumatoid arthritis and osteoarthritis and also shows activity against type II diabetes.

Research Excerpts

Excerpt	Relevance	Reference
"Inflammation is strongly linked to the pathogenesis of T2DM."	3.01	Salsalate: a pleotropic anti-inflammatory drug in the treatment of diabetes, obesity, and metabolic diseases. ( Hasan, I; Rainsford, KD; Ross, JS, 2023)
"Pentosidine level changes were unrelated to changes in levels of renal function, inflammation, or cytokines."	2.79	The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes. ( Barzilay, JI; Fonseca, V; Goldfine, AB; Jablonski, KA; Monnier, VM; Shoelson, SE; Strauch, C, 2014)
"Chronic subacute inflammation is implicated in the pathogenesis of insulin resistance and type 2 diabetes."	2.73	Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. ( Aldhahi, W; Cai, D; Goldfine, AB; Lee, J; Shoelson, SE; Silver, R; Tatro, E, 2008)
"Salicylates have been used as analgesics and antiinflammatory agents for several decades."	2.46	An overview of salsalate as a potential antidiabetic therapy. ( Desouza, CV, 2010)
" The disposition of SS and SA were evaluated simultaneously using a pharmacokinetic model comprising several transit absorption steps and linear and nonlinear dual elimination pathways for SA."	1.38	Pharmacokinetics of salsalate and salicylic acid in normal and diabetic rats. ( Almon, RR; Cao, Y; DuBois, DC; Jusko, WJ, 2012)

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (5.56)	18.2507
2000's	1 (5.56)	29.6817
2010's	15 (83.33)	24.3611
2020's	1 (5.56)	2.80

Authors

Authors	Studies
Hasan, I	1
Rainsford, KD	1
Ross, JS	1
Nie, L	1
Yuan, XL	1
Jiang, KT	1
Jiang, YH	1
Yuan, J	1
Luo, L	1
Cui, SW	1
Sun, C	1
Keller, WR	1
Fischer, BA	1
McMahon, RP	1
Meyer, W	1
Buchanan, RW	1
Goldfine, AB	6
Fonseca, V	4
Jablonski, KA	4
Chen, YD	2
Tipton, L	1
Staten, MA	2
Shoelson, SE	6
Buck, JS	1
Desouza, C	1
Creager, MA	1
Barzilay, JI	1
Strauch, C	1
Monnier, VM	1
Rubin, MR	1
McMahon, DJ	1
Donovan, DS	1
Cremers, S	1
Dworakowski, E	1
Schaefer, EJ	1
Silverberg, SJ	1
Silver, R	1
Aldhahi, W	1
Cai, D	1
Tatro, E	1
Lee, J	1
Pyle, L	1
Nwachukwu, U	1
Pedersen, BK	1
Febbraio, MA	1
Desouza, CV	1
Cao, Y	2
Dubois, DC	2
Sun, H	1
Almon, RR	2
Jusko, WJ	2
Faghihimani, E	1
Aminorroaya, A	1
Rezvanian, H	1
Adibi, P	1
Ismail-Beigi, F	1
Amini, M	1
Rousseau, P	1
Fuentevilla-Clifton, A	1

Clinical Trials (11)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy[NCT02422485]	Phase 1	10 participants (Actual)	Interventional	2015-04-30	Completed
Targeting Inflammation Using Salsalate in CardioVascular Disease (TINSAL-CVD)[NCT00624923]	Phase 2/Phase 3	340 participants (Actual)	Interventional	2008-09-30	Completed
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate[NCT00799643]	Phase 2/Phase 3	638 participants (Actual)	Interventional	2008-11-30	Completed
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate[NCT00392678]	Phase 2/Phase 3	277 participants (Actual)	Interventional	2006-10-31	Completed
The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease: Investigator Initiated Randomized Placebo-controlled Double-blind, Pilot Study[NCT03222206]	Phase 4	34 participants (Actual)	Interventional	2017-11-08	Completed
The Study of Inhibition of Inflammation in the Dysmetabolic Syndrome of Obesity[NCT00258115]	Phase 2	20 participants (Actual)	Interventional	2003-12-31	Completed
Targeting Inflammation to Treat Cardiovascular Aging in Humans (TIVA Study)[NCT01775865]	Phase 2	59 participants (Actual)	Interventional	2012-09-30	Completed
Effect of Salicylate on Glucose Metabolism in Insulin Resistance States[NCT00258128]	Phase 1/Phase 2	17 participants (Actual)	Interventional	2000-01-31	Completed
Regulation of Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease: A Mechanistic Approach[NCT01398943]		60 participants (Actual)	Interventional	2010-09-30	Completed
Acetylsalicylic Acid Administered in Patients With Type 2 Diabetes Mellitus and Its Effect on the Antioxidant Enzyme System[NCT03341117]	Phase 3	21 participants (Actual)	Interventional	2014-12-02	Completed
Using Salsalate to Target Adipocyte Macrophage Infiltration and Reverse Metabolic Disease Risk in Obese Hispanic Young Adults[NCT02130804]	Phase 1	30 participants (Actual)	Interventional	2011-07-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change in Cholesterol

secondary (NCT00624923)
Timeframe: Baseline to 30 mo

Intervention	mg/dL (Mean)
1- Active Pharmacologic	5.1
2- Placebo	2.0

Change in Inflammation in the Liver Associated With Nonalcoholic Steatohepatitis (NASH), ALT

Secondary outcome, change in liver inflammation associated with NASH: ALT (NCT00624923)
Timeframe: baseline to 30 mo

Intervention	U/L (Mean)
1- Active Pharmacologic	-1.1
2- Placebo	-0.6

Change in Inflammation Marker: CRP

Secondary outcome of change in inflammation marker CRP (NCT00624923)
Timeframe: baseline to 30 mo

Intervention	mg/L (Mean)
1- Active Pharmacologic	-0.1
2- Placebo	-0.1

Change in Non-calcified Plaque Volume in the Coronary Arteries Assessed by MDCTA From Baseline to 30 Months

(NCT00624923)
Timeframe: Baseline to 30 months

Intervention	mm^3 (Mean)
1- Active Pharmacologic	0
2-Placebo	0

Change From Baseline in Fasting Glucose Over Time.

(NCT00799643)
Timeframe: 48 weeks from baseline

Intervention	mg/dl (Mean)
Placebo	2.0
Salsalate	-13.1

The Primary Outcome for the TINSAL-T2D Study is Change in HbA1c Level From Baseline to Week 48 From Baseline, Compared Between Treatment Groups.

HbA1c (%, percentage of HbA1c) change from baseline. (NCT00799643)
Timeframe: 48 weeks from baseline

Intervention	HbA1c units are % (Mean)
Placebo	-0.04
Salsalate	-0.33

Change From Baseline and Trends in Fasting Glucose Over Time

(NCT00392678)
Timeframe: 14 week

Intervention	mg/dl (Mean)
Placebo	13
Salsalate 3.0 g/d	-19
Salsalate 3.5 g/d	-14
Salsalate 4.0 g/d	-15

Change From Baseline in 14-week Insulin, C-peptide, Homeostasis Model [HOMA] Index

HOMA-IR was not calcuated due to potential confounding effect of salicylates to inhibit insulin clearance. Change in insulin from Baseline to Week 14 in data table below. (NCT00392678)
Timeframe: Baseline, week 14

Intervention	pmol/l (Median)
Placebo	-3.0
Salsalate 3.0 g/d	15
Salsalate 3.5 g/d	7.6
Salsalate 4.0 g/d	27

Change in HbA1c

Change from baseline to either 14 or 26 weeks, or last HbA1c measurement prior to rescue therapy (NCT00392678)
Timeframe: 14 week

Intervention	% HbA1c (Mean)
Placebo	0
Salsalate 3.0 g/d	-0.4
Salsalate 3.5 g/d	-0.3
Salsalate 4.0 g/d	-0.5

Change in HbA1c Baseline to End of Trial in TINSAL-T2D Stage 1

The primary outcome for the TINSAL-T2D study is change in HbA1c level from baseline to week 14 (stage 1) in the intent-to-treat (ITT) population with last observation carried forward. (NCT00392678)
Timeframe: 14 week

Intervention	% (units of HbA1c) (Mean)
3.0 g/d	-0.36
3.5 g/d	-0.34
4.0 g/d	-0.49
Placebo	-0.01

Change in Insulin, C-peptide, Homeostasis Model [HOMA] Index

HOMA-IR was not calcuated due to potential confounding effect of salicylates to inhibit insulin clearance. Change in C-peptide from Baseline to Week 14 is in the data table below (NCT00392678)
Timeframe: Baseline, week 14

Intervention	C-peptide in nmol/l (Mean)
Placebo	0.10
Salsalate 3.0 g/d	-0.07
Salsalate 3.5 g/d	-0.03
Salsalate 4.0 g/d	0.03

Safety and Tolerability

See adverse event module for details. Safety and tolerability of salsalate compared to placebo as assessed by adverse events. (NCT00392678)
Timeframe: 14 weeks

Intervention	participants (Number)
Salsalate 3.0 g/d	17
Salsalate 3.5 g/d	16
Salsalate 4.0 g/d	16
Placebo	14

Change in Lipids

"Change in lipids (low-density lipoprotein cholesterol [LDL-C], non-high-density lipoprotein cholesterol [non-HDL-C], triglycerides [TG], total cholesterol [TC], high-density lipoprotein cholesterol [HDL C], TC/HDL-C ratio, and LDL-C/HDL-C ratio)~LDL-C/HDL-C ratio not calculated" (NCT00392678)
Timeframe: 14 week

,,,

Intervention	mg/dl (Mean)
	Cholesterol	HDL	LDL	TG	Total to HDL ratio
Placebo	0	0	0	15	0
Salsalate 3.0 g/d	8	3	15	-34	0.1
Salsalate 3.5 g/d	-1	1	3	-22	-0.1
Salsalate 4.0 g/d	6	2	8	-16	0.2

Brachial Artery Flow-mediated Dilation (FMD)

Endothelial function (NCT01775865)
Timeframe: Change from baseline brachial artery FMD at 4 weeks

Intervention	Percent dilation (Mean)
	Baseline	4 Weeks
Placebo	3.57	2.50
Salsalate	3.49	4.60
Young Control Group	5.88	NA

Carotid-femoral Pulse Wave Velocity (CFPWV)

Aortic stiffness (NCT01775865)
Timeframe: Change in CFPWV from baseline at 4 weeks

Intervention	cm/sec (Mean)
	Baseline	4 weeks
Placebo	785.1	740.01
Salsalate	831.3	839.6
Young Control Group	538.0	NA

Adiponectin

(NCT00258128)
Timeframe: 4 weeks

Intervention	mg/ml (Mean)
Salsalate	22.7
Placebo	10.6

Glucose

fasting glucose (NCT00258128)
Timeframe: 4 weeks

Intervention	mmol/L (Mean)
Placebo	7.1
Salsalate	6.4

Flow-Mediated Dilation (FMD)

Brachial artery FMD induced by reactive hyperemia will be used to assess vascular endothelial function at baseline and several hours after each experimental intervention. (NCT01398943)
Timeframe: Post FMD was taken approximately 110 min after baseline

Intervention	percentage of change in FMD (Mean)
	Placebo	AOC Treatment
All Controls	6.7	6.9
All COPD Patients	3.1	4.7

Pulse Wave Velocity

A measure of vascular stiffness at baseline and several hours after each experimental intervention. (NCT01398943)
Timeframe: Post PWV was taken approximately 90 min after baseline

Intervention	m/sec (Mean)
	Placebo	AOC Treatment
All Controls	11	10
All COPD Patients	14	11

Reviews

2 reviews available for salicylsalicylic acid and Diabetes Mellitus, Adult-Onset

Article	Year
Salsalate: a pleotropic anti-inflammatory drug in the treatment of diabetes, obesity, and metabolic diseases. Inflammopharmacology, 2023, Volume: 31, Issue:6 Topics: Anti-Inflammatory Agents; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Inflammation; Inte	2023
An overview of salsalate as a potential antidiabetic therapy. Drugs of today (Barcelona, Spain : 1998), 2010, Volume: 46, Issue:11 Topics: Animals; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Ag	2010

Trials

7 trials available for salicylsalicylic acid and Diabetes Mellitus, Adult-Onset

Article	Year
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus,	2013
Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes care, 2013, Volume: 36, Issue:12 Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Brachial Artery	2013
The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes. Diabetes care, 2014, Volume: 37, Issue:4 Topics: Adiponectin; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Diabetes Mellitus, Type 2; Di	2014
Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus. Endocrine, 2015, Volume: 50, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Bone Remodeling; Diabetes Mellitus, Type 2; Hum	2015
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and translational science, 2008, Volume: 1, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dose	2008
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes. Acta diabetologica, 2013, Volume: 50, Issue:4 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus, Type 2; Fema	2013
Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes. Acta diabetologica, 2013, Volume: 50, Issue:4 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus, Type 2; Fema	2013
Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes. Acta diabetologica, 2013, Volume: 50, Issue:4 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus, Type 2; Fema	2013
Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes. Acta diabetologica, 2013, Volume: 50, Issue:4 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus, Type 2; Fema	2013

Other Studies

9 other studies available for salicylsalicylic acid and Diabetes Mellitus, Adult-Onset

Article	Year
Salsalate Activates Skeletal Muscle Thermogenesis and Protects Mice from High-Fat Diet Induced Metabolic Dysfunction. EBioMedicine, 2017, Volume: 23 Topics: Adipose Tissue, White; Animals; Body Weight; Cell Line; Diabetes Mellitus, Type 2; Diet, High-Fat; E	2017
Open-label salsalate for the treatment of pre-diabetes in people with schizophrenia. Schizophrenia research, 2013, Volume: 147, Issue:2-3 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Diabetes Mellitus, Type	2013
Summaries for patients. Salsalate for type 2 diabetes mellitus. Annals of internal medicine, 2013, Jul-02, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Huma	2013
Summaries for patients. The effects of salsalate on blood sugar control in people with type 2 diabetes. Annals of internal medicine, 2010, Mar-16, Volume: 152, Issue:6 Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method;	2010
Health trends. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2010, Volume: 25, Issue:4 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Blood Glucose; Bone Density Conservation Ag	2010
Diabetes: Treatment of diabetes mellitus: new tricks by an old player. Nature reviews. Endocrinology, 2010, Volume: 6, Issue:9 Topics: Anti-Inflammatory Agents, Non-Steroidal; Diabetes Mellitus, Type 2; Endocrinology; History, 19th Cen	2010
Modeling diabetes disease progression and salsalate intervention in Goto-Kakizaki rats. The Journal of pharmacology and experimental therapeutics, 2011, Volume: 339, Issue:3 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Body Weight; Diabetes Mellitus, Typ	2011
Pharmacokinetics of salsalate and salicylic acid in normal and diabetic rats. Biopharmaceutics & drug disposition, 2012, Volume: 33, Issue:6 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Dia	2012
Acetazolamide and salicylate interaction in the elderly: a case report. Journal of the American Geriatrics Society, 1993, Volume: 41, Issue:8 Topics: Acetazolamide; Acidosis, Lactic; Aged; Anorexia; Confusion; Coronary Disease; Diabetes Mellitus, Typ	1993